exagger
complement
activ
key
event
pathogenesi
rang
autoimmun
inflammatori
diseas
complement
receptor
emerg
molecul
immens
interest
gain
insight
suscept
pathophysiolog
diagnosi
prognosi
therapi
diseas
review
bring
forth
composit
view
current
understand
structur
function
genet
diseas
associ
therapeut
implic
complement
receptor
receptor
complement
peptid
iida
et
al
present
differ
cell
plasma
urin
drawn
huge
attent
scientist
gene
polymorph
structur
varianc
divers
function
diseas
associ
potenti
diagnost
prognost
marker
increasingli
realiz
extens
research
brought
insight
pathophysiolog
galaxi
diseas
includ
autoimmun
inflammatori
disord
studi
anim
model
suggest
therapeut
inflammatori
chain
reaction
tissu
damag
sever
diseas
review
attempt
give
composit
current
view
differ
aspect
special
emphasi
diseas
associ
therapeut
implic
protein
lar
surfac
except
lack
cytoplasm
tail
gener
proteolyt
cleavag
ctermin
region
transmembran
domain
surfac
molecul
hamer
et
al
complement
receptor
multipl
action
defin
role
complement
regulatori
protein
fig
molecul
act
receptor
therebi
destabil
enhanc
decay
classic
pathway
covertas
altern
pathway
covertas
iida
nussenzweig
anoth
promin
function
activ
cofactor
factor
mediat
inactiv
ross
et
al
medof
nussenzweig
act
anoth
step
regul
altern
pathway
role
mbl
receptor
ghiran
et
al
may
involv
regul
mbl
pathway
complement
activ
erythrocyt
abl
bind
opson
immun
complex
yoshida
et
al
local
erythrocyt
membran
fig
immun
complex
thu
trap
transfer
macrophag
liver
spleen
cosio
et
al
craig
et
al
kupffer
cell
larg
phagocyt
liver
spleen
engulf
metabol
immun
complex
van
es
daha
skogh
et
al
variou
immun
complex
particl
coat
polymer
recogn
molecul
polymorphonuclear
pmn
cell
monocyt
particulari
clathrin
coat
pit
fearon
et
al
abrahamson
fearon
fcgamma
receptor
oper
synerg
promot
uptak
particl
opson
immunoglobulin
complement
protein
particl
intern
destroy
lysosom
fig
ehlenberg
nussenzweig
schorlemm
et
al
receptor
molecul
present
cytoplasm
secretori
vesicl
demonstr
neutrophil
transloc
plasma
membran
cell
activ
sengelov
et
al
complement
receptor
present
bcell
appear
control
prolifer
bcell
fingeroth
et
al
occupi
ligand
stimulatori
drive
suboptim
antiigm
fab
fail
bring
bcell
prolifer
fig
jozsi
et
al
erdei
et
al
physiolog
import
interact
may
relat
inhibit
bcell
activ
weak
antigen
stimuli
evok
autoantigen
although
presenc
lymphocyt
prove
rodgaard
et
al
function
signific
clear
increas
express
poli
clonal
activ
cell
demonstr
suggest
possibl
role
tcell
mediat
immun
regul
rodgaard
et
al
appear
highli
efficaci
complement
regulatori
antiinflammatori
activ
hamer
et
al
physiolog
plasma
level
howev
low
signific
function
role
pascual
et
al
solubl
isol
bronchoalveolar
lavag
patient
inflammatori
lung
disord
hamach
et
al
plasma
patient
suffer
hepat
renal
failur
lymphoma
leukemia
pascual
et
al
increas
level
plasma
also
report
sle
glomerulonephr
da
et
al
hypothes
local
activ
molecul
envisag
molecul
choic
variou
novel
therapeut
strategi
complement
receptor
gene
locat
chromosom
locu
wei
et
al
map
region
regul
complement
activ
rca
gene
cluster
rodriguez
de
cordoba
rubinstein
variou
gene
polymorph
studi
gene
varianc
may
rang
grossli
molecular
weight
alter
insertiondelet
polymorph
minim
protein
alter
intron
exon
singl
nucleotid
polymorph
affect
densiti
molecul
cell
surfac
addit
two
anoth
set
polymorph
gener
singl
nucleotid
polymorph
alter
protein
gener
separ
group
blood
group
antigen
variant
knop
blood
group
antigen
intron
polymorph
hindiii
rflp
intron
densiti
polymorph
variou
polymorph
studi
abil
alter
densiti
erythrocyt
cell
membran
might
differ
differ
individu
owe
specif
genotyp
composit
wilson
level
leucocyt
show
variabl
like
hindiii
restrict
fragment
length
polymorph
hindiii
rflp
correspond
singl
nucleotid
polymorph
intron
singl
base
substitut
c
gene
wilson
et
al
hindiii
kb
genom
fragment
associ
high
express
allel
h
allel
kb
hindiii
genom
fragment
associ
low
express
allel
l
allel
presenc
sever
exon
singl
tabl
polymorph
code
sequenc
xiang
et
al
nucleotid
polymorph
snp
xiang
et
al
tabl
linkag
disequilibrium
hindiii
rflp
polymorph
suggest
probabl
mechan
alter
intron
hindiii
rflp
h
allel
consid
contain
g
c
encod
gln
pro
l
allel
consid
contain
g
g
encod
arg
arg
varianc
amino
acid
composit
suggest
influenc
stabil
protein
level
show
trimod
distribut
high
express
phenotyp
molecul
per
cell
associ
homozyg
h
intermedi
express
heterozyg
hl
low
express
molecul
per
cell
homozyg
l
genotyp
caucasian
xiang
et
al
indian
katyal
et
al
african
row
et
al
protein
four
known
allotyp
variant
vari
size
r
kda
kda
dykman
et
al
dykman
et
al
dykman
et
al
posttransl
modif
unglycosyl
primari
transcript
possess
variat
lublin
et
al
genom
differ
allotyp
rang
kb
equival
singl
lhr
wong
et
al
insertiondelet
mechan
due
unequ
cross
chromosom
consid
respons
variat
kda
kda
kda
kda
four
variant
analyz
sdspage
nonreduc
condit
van
dyne
et
al
lhr
repeat
give
addit
bind
site
larger
variant
small
one
site
function
implic
howev
clear
frequent
allel
f
allotyp
allotyp
follow
allel
rare
dykman
et
al
mould
et
al
gene
frequenc
caucasian
african
american
mexican
mould
et
al
asian
indian
katyal
et
al
aa
ab
preval
genotyp
popul
studi
polymorph
birmingham
et
al
character
exon
snp
lead
replac
singl
guanin
thymin
polymorph
bind
site
ligand
xiang
et
al
drawn
special
attent
relat
sever
plasmodium
falciparum
malaria
thoma
et
al
variou
antigen
studi
group
includ
allel
pair
kn
kn
b
knop
mcc
mcc
b
mccoy
sl
vil
swainlangleyvillien
yk
york
mould
daniel
et
al
antigen
identifi
occurr
high
avid
noncompl
fix
nonhemolys
antibodi
circul
subsequ
identifi
correspond
antigen
present
molecul
mould
et
al
rao
et
al
gene
code
locat
lhrd
region
gene
mould
et
al
tamasauska
et
al
recent
sl
subclassifi
variou
conform
variant
mould
variou
knop
blood
group
genotyp
gener
singl
nucleotid
polymorph
exon
identif
knop
blood
group
antigen
phenotyp
indic
discoveri
serolog
null
phenotyp
helgeson
phenotyp
knop
blood
group
show
reduc
level
mould
et
al
associ
knop
blood
group
malaria
variou
inflammatori
disord
topic
interest
mani
present
day
research
extens
research
brought
new
insight
diagnosi
prognosi
pathophysiolog
therapi
diseas
differ
domain
studi
howev
remain
focus
autoimmun
disord
autoimmun
disord
correl
multipl
factor
consider
studi
pathogen
mechan
involv
autoimmun
tissu
injuri
one
mechan
relat
etiopathogenesi
autoimmun
disord
suggest
bound
selfantigen
present
molecul
bone
marrow
stromal
cell
lead
downregul
autoreact
bcell
henc
maintain
bcell
toler
prodeu
et
al
effect
end
serv
protect
host
tissu
clear
immun
complex
deposit
vasculatur
glomeruli
synovium
lead
tissu
damag
complement
activ
fcmediat
phlogistogenesi
addit
complement
regulatori
function
may
import
role
amelior
autoimmun
hosttissu
destruct
complement
receptor
studi
extens
relat
system
lupu
erythematosu
sle
shown
sle
mark
declin
level
erythrocyt
corvetta
et
al
birmingham
et
al
leukocyt
fyfe
et
al
glomerular
podocyt
arora
et
al
raju
et
al
sever
mechan
suggest
explain
declin
cell
surfac
diseas
inherit
l
allel
hindiii
densiti
polymorph
envisag
caus
low
level
patient
intens
investig
howev
refut
assumpt
mitchel
et
al
kumar
et
al
nevertheless
studi
shown
posit
correl
l
allel
sle
wilson
et
al
reduct
level
transfus
rbc
activ
sle
patient
show
nongenotypespecif
reduct
walport
et
al
thu
studi
carri
mani
ethnic
group
found
associ
l
c
allel
diseas
mould
et
al
studi
india
demonstr
highli
signific
associ
hh
genotyp
h
allel
immun
complexmedi
glomerulonephr
greater
loss
erythrocyt
observ
patient
carri
hh
genotyp
l
allel
thu
appear
protect
specul
compens
mechan
inherit
low
express
genotyp
inherit
hh
genotyp
katyal
et
al
inherit
low
level
stand
true
low
level
sle
patient
believ
low
level
sle
acquir
holm
et
al
shown
highli
suscept
tryptic
cleavag
ripoch
sim
stump
peptid
possibl
proteolyt
cleavag
demonstr
podocyt
sever
sle
associ
glomerulopathi
barbosa
et
al
teixeira
et
al
indirect
find
suggest
decreas
level
seen
variou
inflammatori
malign
disord
also
higher
level
serum
proteas
like
elastas
curri
et
al
cell
like
mesangi
cell
possibl
circulatori
cell
may
respons
pericellular
proteolysi
cell
termin
complex
complement
deposit
onto
cell
membran
adler
et
al
lovett
et
al
may
possibl
cleav
surfac
molecul
supersatur
complement
activ
immun
complex
diseas
henc
mechan
acquir
loss
wide
accept
although
enhanc
proteolyt
cleavag
stood
plausibl
mechan
low
level
sle
possibl
reduc
synthesi
put
mechan
entir
ignor
evid
valid
absenc
stump
glomerular
podocyt
express
low
level
moll
et
al
posit
correl
level
sle
patient
mark
declin
level
sivasankar
et
al
presumpt
mechan
express
modul
nuclear
cell
might
differ
envisag
erythrocyt
arora
et
al
conduct
seri
experi
leucocyt
neutrophil
healthi
individu
patient
sle
evidenc
reduc
gene
transcript
enhanc
proteolyt
cleavag
defect
target
vesicular
cell
membran
collect
contribut
mark
declin
leukocyt
sle
arora
et
al
fig
although
less
studi
comparison
sle
similar
pattern
involv
indic
mani
autoimmun
disord
like
sle
rheumatoid
arthriti
express
erythrocyt
reduc
kumar
et
al
shown
acquir
charact
kumar
et
al
howev
report
suggest
higher
level
express
ra
jone
et
al
low
express
along
molecul
regul
complement
activ
rca
alpha
block
major
suscept
mechan
primari
syndrom
lester
et
al
acquir
loss
also
report
insulindepend
diabet
mellitu
iddm
ruuska
et
al
differenti
pattern
express
erythrocyt
glomerular
podocyt
report
immun
complex
mediat
nonimmun
complexmedi
minim
chang
nephrit
syndrom
raju
et
al
dread
complic
p
falciparum
malaria
massiv
hemolysi
anemia
cerebr
malaria
renal
failur
hypoglycemia
acidosi
macroscop
hemoglobinuria
mani
other
explain
basi
two
broad
etiopathogenet
mechan
first
mechan
suggest
microvasular
obstruct
brought
roset
erythrocyt
microvasculatur
variou
vital
organ
second
mechan
suggest
immun
complex
mediat
kaul
et
al
immun
complex
multipl
downstream
pathway
complement
activationinduc
metabol
dysfunct
caus
tissu
injuri
multiorgan
failur
june
et
al
nagayasu
et
al
none
suggest
mechan
could
explain
complic
molecul
especi
capac
contribut
rosett
format
immun
complex
clearanc
wide
studi
aim
deciph
marker
sever
well
target
immuneprophylaxi
therapeut
strategi
intraerythrocyt
phase
malari
parasit
present
p
falciparum
erythrocyt
membran
erythrocyt
membran
interact
multipl
receptor
promin
erythrocyt
lead
erythrocyt
roset
clump
row
et
al
mechan
great
extent
explain
role
malari
complic
aris
microvascular
obstruct
patholog
mainli
cerebr
malaria
aspect
involv
includ
clearanc
immun
complex
cosio
et
al
role
well
studi
variou
autoimmun
disord
particular
interest
associ
densiti
polymorph
sever
malaria
hindiii
rflp
shown
variabl
relationship
sever
hh
genotyp
increas
number
increas
mediat
roset
associ
sequela
genotyp
although
associ
reduc
roset
advers
affect
capac
erythrocyt
clear
immun
complex
associ
malari
infect
owe
reduc
level
argument
support
sever
correl
differ
group
popul
caucasian
studi
group
cockburn
et
al
show
sever
correl
hh
genotyp
studi
thai
popul
nagayasu
et
al
shown
low
roset
high
immun
complex
state
genotyp
correl
malari
sever
expect
metabol
pattern
sever
domin
southeast
asian
countri
nagayasu
et
al
african
popul
shown
correl
densiti
malari
sever
hind
iii
rflp
genotyp
row
et
al
select
pressur
malaria
seen
affect
select
mani
polymorph
exon
polymorph
locat
bind
domain
thoma
et
al
may
emerg
effect
marker
malari
sever
preliminari
unpublish
work
work
madhukar
et
al
da
et
al
madhukar
et
al
da
et
al
present
keyston
symposium
albach
austria
shown
malaria
sever
correl
hindiii
rflp
knop
blood
group
antigen
specif
mccoy
swainlangley
group
role
play
malari
pathogenesi
sl
antigen
variant
shown
rosett
less
effici
sl
row
et
al
shown
chanc
cerebr
malaria
reduc
sl
mcc
ab
genotyp
compar
sl
mcc
aa
henc
possibl
si
tabl
phenotyp
frequenc
knop
blood
group
polymorph
variou
ethnic
group
mcc
tabl
mould
et
al
anoth
studi
gambia
fail
find
associ
malari
sever
knop
blood
group
antigen
zimmerman
et
al
relat
hiv
infect
multidimension
effect
observ
establish
infect
episod
exacerb
diseas
condit
susten
infect
antiretrovir
therapi
level
associ
hiv
diseas
progress
well
complement
opson
lymphotrop
strain
hiv
shown
infect
monocyt
cell
even
suboptim
viral
concentr
similar
unopson
hiv
infect
concentr
activ
attribut
complement
receptor
receptor
monocyt
monocyt
treat
monoclon
treat
remain
uninfect
hiv
thieblemont
et
al
similar
mechan
infect
thymocyt
also
propos
delibria
et
al
replic
hiv
lymphocyt
shown
enhanc
activ
molecul
aggreg
mouhoub
et
al
suggest
mechan
increas
hiv
viremia
decompens
aidsrel
complex
aid
bear
immun
complex
particl
cooccur
infect
hiv
infect
treat
antiretrovir
therapi
lead
complement
depend
bind
hiv
particl
along
hivimmun
complex
erythrocyt
montefiori
et
al
horakova
et
al
caus
persist
infect
even
viru
may
undetect
blood
newer
studi
reveal
bind
opson
hiv
transient
natur
factor
imedi
process
present
hiv
help
transfer
hiv
particl
express
bcell
subject
bcell
mediat
transfer
tcell
fig
banki
et
al
import
lead
investig
role
mani
diseas
uptak
mycobacterium
tuberculosi
monocytesmacrophag
partli
mediat
monocyt
block
certain
extent
monoclon
antibodi
declin
adher
tuberculosi
schlesing
et
al
observ
preliminari
investig
indic
upregul
tuberculosi
solubl
antigen
esat
preliminari
find
accept
present
xxii
icw
data
shown
patient
carcinoma
gallbladd
level
found
invers
proport
degre
cancer
invas
distant
metastasi
henc
diseas
sever
declin
level
found
acquir
phenomenon
jiao
et
al
leishmani
infect
receptor
shown
involv
bind
leishamania
major
metacycl
promastigot
human
macrophag
da
silva
et
al
rosenth
et
al
level
declin
phase
initi
progress
sever
acut
respiratori
syndrom
sar
wang
et
al
express
neutrophil
patient
sever
atop
dermat
higher
mild
form
diseas
yoshida
et
al
account
diseas
associ
form
basi
explor
import
diseas
marker
inform
avail
relat
sle
sivasankar
et
al
suggest
urinari
marker
diagnos
glomerular
involv
sle
verma
et
al
casecontrol
studi
found
level
leukocyt
transcript
much
lower
patient
lupu
nephriti
compar
nonnephr
patient
suggest
role
diseas
sever
marker
sle
arora
et
al
da
et
al
casecontrol
studi
follow
studi
found
signific
correl
level
neutrophil
transcript
protein
diseas
activ
show
neg
correl
level
transcript
diseas
activ
prognost
cours
hiv
mean
valu
estim
aid
aid
relat
syndrom
gave
signific
trend
jouvin
et
al
found
level
asymptomat
seroposit
individu
patient
persist
gener
lymphadenopathi
pgl
differ
significantli
normal
subject
level
decreas
patient
aid
relat
complic
p
patient
suffer
aid
p
level
show
neg
correl
sever
diseas
cohen
et
al
loss
aid
consid
acquir
rather
inherit
phenomenon
discuss
earlier
gene
strong
candid
predict
suscept
sever
malaria
also
nomin
candid
gene
assess
suscept
sarcoidosi
basi
casecontrol
studi
linkag
analysi
iannuzzi
et
al
femal
low
express
genotyp
shown
higher
tendenc
develop
preeclampsia
ie
gestationinduc
hypertens
guo
qian
feinberg
et
al
associ
hh
genotyp
hind
iii
polymorph
immun
complex
glomerulonephr
suggest
katyal
et
al
larg
studi
remain
confin
hindiii
densiti
structur
polymorph
grow
evid
exist
mani
differ
snp
gene
xiang
et
al
extens
analysi
gene
need
carri
addit
provid
insight
molecular
pathogenesi
mani
disord
molecul
owe
multifunct
natur
promis
therapeut
agent
solubl
form
though
function
activ
normal
present
low
concentr
plasma
recombin
form
design
assess
therapeut
potenti
recombin
bind
site
activ
cofactor
factor
therapeut
efficaci
assess
variou
autoimmun
inflammatori
disord
weisman
et
al
anim
model
experi
valid
resolut
inflammatori
chang
accompani
inflammatori
lung
injuri
rabinovici
et
al
myocardi
infarct
weisman
et
al
autoimmun
thyroid
metcalf
et
al
glomerulonephr
couser
et
al
use
recombin
solubl
use
manag
incompat
blood
transfus
inhibit
complement
activ
subsequ
immun
hemolysi
suggest
yazdanbakhsh
scaradav
sinc
potenti
prevent
ereset
clear
immun
complex
patient
envisag
therapeut
sever
falciparum
malaria
cockburn
et
al
solubl
long
expect
amelior
suffer
variou
diseas
condit
studi
promis
revolut
health
care
strategi
base
anim
model
diseas
weisman
et
al
rabinovici
et
al
couser
et
al
may
limit
valu
light
import
speci
differ
mechan
immun
complex
clearanc
antirh
complex
design
target
add
extra
molecul
defici
erythrocyt
variou
disord
oudin
et
al
fig
anoth
strategi
involv
use
antigenbas
heteropolym
ahp
dsdna
molecul
bound
mononclon
antibodi
molecul
would
specif
bind
antidsdna
target
facilit
remov
antid
dna
circul
faster
rate
ferguson
et
al
anoth
recent
molecul
sialyl
lewi
x
hybrid
solubl
complement
receptor
x
picard
et
al
develop
fragment
act
complement
inhibitor
sle
x
act
inhibit
selectinmedi
interact
lymphocyt
neutrophil
endothelium
x
propos
use
ischemiareperfus
injuri
thermal
injuri
immun
complex
mediat
injuri
asghar
pasch
efficaci
prevent
lung
ischemiareperfus
injuri
well
stroke
reperfus
injuri
studi
extens
stammberg
et
al
ducruet
et
al
preclin
evalu
x
conduct
nonhuman
primat
model
reperfus
stroke
termin
prematur
unabl
perform
propos
function
reduc
infarct
volum
also
caus
unfavor
reaction
ducruet
et
al
thu
emphas
need
research
molecul
purpos
specif
inhibit
autoreact
cell
characterist
autoimmun
disord
dna
complex
design
specif
inhibit
autoreact
bcell
dna
mimotop
includ
specif
bind
abil
antidsdna
antibodi
secret
bcell
act
bcell
inhibitor
fig
voynova
et
al
method
fight
grow
antibiot
resist
bacteria
immunotherapeut
strategi
experi
treatment
resist
staphylococcu
aureu
infect
bispecif
monoclon
antibodi
complex
heteropolym
hp
specif
type
capsular
polysaccharid
isol
aureu
design
promot
bind
aureu
erythrocyt
via
subsequ
transfer
monocyt
macrophag
intern
bacteri
kill
gyimesi
et
al
also
studi
import
molecul
circumv
hyperacut
tissu
reject
occur
allogen
transplant
cell
transfect
recombin
hammel
et
al
manzi
et
al
phosphatidyl
inositolbound
mini
mikata
et
al
show
enhanc
surviv
subject
condit
simul
hyper
acut
reject
result
arous
great
interest
scientist
world
strategi
still
nascent
stage
long
way
go
readi
use
none
strategi
outlin
test
beyond
anim
model
respect
diseas
howev
find
ing
promis
revolutionari
therapeut
strategi
center
increas
realiz
close
relationship
diseas
patholog
level
express
desir
factor
contribut
mainten
normal
level
modul
diseas
state
unravel
effect
sever
cytokin
context
investig
depend
type
cell
variabl
effect
observ
limb
et
al
observ
tnf
increas
level
monocyt
chemotact
peptid
shown
upregul
differ
cell
test
doi
et
al
recent
investig
found
increas
level
transcript
neutrophil
healthi
individu
patient
sle
arora
et
al
suppress
effect
express
da
et
al
data
shown
present
foci
elucid
factor
respons
declin
transcript
sle
found
serum
opson
immun
complex
reduc
level
transcript
neutrophil
healthi
individu
well
patient
arora
et
al
howev
effect
express
immun
complex
opson
direct
effect
express
suppress
express
find
immun
complex
emerg
major
factor
respons
declin
sle
arora
et
al
studi
differ
cell
line
shown
retino
acid
upregul
express
mucida
et
al
interest
relationship
hindiii
polymorph
modul
level
immun
complex
observ
anand
msc
thesi
data
public
observ
hl
genotyp
respons
either
upregul
downregul
level
immun
complex
respect
give
clue
asian
indian
l
allel
appear
protect
sle
conclud
complement
receptor
ideal
target
translat
research
ampl
evid
suggest
multifacet
associ
complement
receptor
vast
array
diseas
function
versatil
protein
structur
varianc
complement
receptor
genet
relationship
diseas
process
open
fascin
area
research
extrem
import
molecul
diseas
process
immun
complex
deposit
excess
complement
system
activ
result
tissu
damag
biolog
role
allow
futur
candid
marker
determin
diseas
suscept
diagnosi
prognosi
variou
trial
anim
model
therapeut
establish
molecul
chain
breaker
complementmedi
inflammatori
reaction
subsequ
organ
damag
variou
aspect
assembl
review
may
intensifi
investig
achiev
better
insight
larg
number
diseas
open
novel
therapeut
strategi
